References
- Khan MA. Ankylosing Spondylitis: clinical features. In Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby Year Book 1994;25:1–10.
- Leirisalo-Repo M. Therapeutic aspects of spondyloarthropa-thies - a review. Scand J Rheumatol 1998;27:323–8.
- Toussirot E, Wendling D. Current Guidelines for the drug treatment of Ankylosing Spondylitis. Drugs 1998;56:225–40.
- CalM A, Elswood J. A prospective Nationwide cross-sectional study of NSAID usage in 1331 patients with Ankylosing Spondylitis. J Rheumatol 1990:17;801–3.
- Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Metaanalysis of Sulfasalazine in ankylosing spondylitis. J Rheumatol 1990;17:1482–6.
- Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993;32: 729–33.
- Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. Arthritis Rheum 1996;39:2004–12.
- Fraser SM, Sturrock RD. Evaluation of sulphasalazine ankyl-osing spondylitis-an interventional study. Br J Rheumatol 1990;29:37–9.
- Kremer JM. Methotrexate update (editorial). Scand J Rheumatol 1996;25:341–4.
- Cannon GW, Reading JC, Ward JR, Blonquist LJ, Collette LB. Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate. Scand J Rheumatol 1990;19:285–94.
- Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 1984;11:760–3.
- Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 1985;103:489–96.
- Van der Veen MJ, Scheven BAA, van Roy JLAM, Damen CA, Lafeber FPJG, Bijlsma JWJ. In vitro effects of methotrex-ate on human articular cartilage and bone-derived osteoblasts. Br J Rheumatol 1996;35:342–9.
- Abu-Shakra M, Gladman DD, Thorne JC, Long J, Gough J, Farewell VT. Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J Rheumatol 1995;22:241–5.
- Van den Hoogen FHJ, Boerbooms AMT, Swaak AJG, Rasker JJ, van Lier HJJ, van de Putte LBA. Comparison of methotrex-ate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol 1996;35:364–72.
- Gran JT. Current therapy of polymyalgia rheumatica (editorial). Scand J Rheumatol 1999;28:269–72.
- Creemers MCW, Franssen MJAM, van de Putte LBA, Gribnau FJW, van Riel PLCM. Methotrexate in severe ankyl-osing spondylitis: an open study. J Rheumatol 1995;22:1104–7.
- Ferraz MB, Carrico da Silva H, Atra E. Low dose methotrexate with leucoverin rescue in AS. J Rheumatol 1991;18:146–7.
- Handler RP. Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis. Arthritis Rheum 1989;32:234.
- Yamane K, Saito C, Natsuda H, Yuhara T, Akama T, Suzuki H, et al. Ankylosing spondylitis successfully treated with methotrexate. Intern Med 1993;32:53–6.
- Sampaio-Barros PD, Costallat LTL, Bertolo MB, Francisco J, Neto M, Samara AM. Methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 2000;29:160–2.
- Mander MM, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987;46:197–202.
- Dougados M, Gueguin A, Nakache J, Nguyen M, Mery C, Amor B. Evaluation of functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302–7.
- Creemers MCW, van't Hof MA, Franssen MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM. A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study. Br J Rheumatol 1994;33:842–6.